Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether his Department has received any representations from (a) medical and (b) ethnobotanical researchers on the potential therapeutic uses of Kava since 2020.

The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for the regulation of medicines, medical devices, and blood components for transfusion in the United Kingdom, this includes the regulation of herbal medicinal products.

The MHRA received requests in 2023 and 2024 to reconsider or remove Kava-kava from the UK’s list of restricted or banned herbal products, in order to allow the traditionally prepared beverage containing Kava-kava, used medicinally to treat anxiety and insomnia, to be marketed in the UK.

The MHRA indicated that an application for a marketing authorisation or a traditional herbal registration would be required to place any medicinal product on the UK market, and provided information about the requirements. Applications for authorised products are exempt from the Statutory Instrument 2002 No. 3170 The Medicines for Human use (Kava-kava) (Prohibition) Order 2002. However, no application has been received by the MHRA.